Early Access — free while we kick the tires
EdgarHawk

Ajay Royan

Director

Director 10% Owner

Latest: Director buying · June 2026

2 filings analyzed · 1 company · Latest 2026-06-15

Never miss a filing from Ajay Royan

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
FRACTYL HEALTH, INC. GUTS 2 0 Net buying

Activity

June 2026
2026-06-15 FRACTYL HEALTH, INC. GUTS Cluster
medium
Buy
23,000 shares
$19,596
Significance 4/10

Director Ajay Royan bought 23,000 shares of GUTS at $0.85, raising stake 128.5%; 4-insider cluster buy amid -100.0% revenue decline.

Ajay Royan (Director) purchased 23,000 shares at $0.85 on 2026-06-12, doubling his stake from 17,901 to 40,901 shares. The buy occurs within a cluster pattern: 4 other insiders also purchased within the past 14 days. The stock is trading at -70.7% from its 52-week high of $2.90, and the company reported a -100.0% annual revenue decline with a full-year net loss, though the latest quarter showed $14,000 revenue and $9.2M net income. His prior two purchases at GUTS produced mixed 90-day outcomes (+69.0% and -57.7%); only 1 of 2 was well-timed. The concurrent multi-insider buying activity, combined with the depressed price relative to recent range, provides a factual baseline for monitoring whether this signals substantive conviction or reflects a cyclical bottom-fishing pattern typical of distressed-stage holdings.

March 2025
2025-03-18 FRACTYL HEALTH, INC. GUTS
medium
Buy
17,901 shares
$22,980
Significance 3/10

Director Royan Ajay buys 17,901 shares of FRACTYL (GUTS) at $1.28 on 2025-03-14; stock down 84.2% from 52-week high, company unprofitable with -$23.2M net income.

Director Royan Ajay purchased 17,901 shares at $1.28, his first acquisition at GUTS, amid significant stock deterioration: the security is -84.2% from its 52-week high and -22.2% over 30 days. The company is deeply unprofitable (net income of -$23.2M on quarterly revenue of $14.0K) with annual revenue declining -22.5%. A cluster of 4 other insiders also bought within the past 14 days, suggesting coordinated interest despite the challenging fundamentals. However, Ajay's own cross-ticker buy history shows 0% win rate at 90 days with an average return of -57.7%, and his single prior GUTS purchase on 2024-02-06 also lost -57.7% over 90 days, establishing a pattern of poor timing in this name specifically. The combination of deteriorating financials, steep price decline, and the insider's unprofitable trade history at this ticker warrants investor scrutiny.

Related insiders